Ophthalmologists: Will 2015 Make You or Break You?
Post# of 30013
![Avatar](/images/ProfileImages/1996739806_13310_Entertained 3.jpg)
January 30, 2015
Orphan drug approval. In December 2014, the US Food and Drug Administration (FDA) gave orphan drug approval to mesencephalic astrocyte-derived neurotrophic factor as a treatment for retinitis pigmentosa. The naturally occurring protein works by inhibiting apoptosis. "That's exciting because it's bringing cells back to life," says Dr Bhavsar.
http://www.medscape.com/viewarticle/838877
Dr. Abdhish Bhavsar, MD is a retina specialist and a clinical spokesman for the American Academy of Ophthalmology.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)